foxo4-dri senolytic peptide animal study Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI regulates endothelial cell senescence

Name: foxo4-dri senolytic peptide animal study Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI regulates endothelial cell senescence
Brand: oogcentrumvisie.be
SKU: 68891845176
Price: 27.55 USD
Availability: InStock
Rating: 4.0081 (30 reviews)

SKU: 68891845176

4.0

SEK27.55 SEK70.55

Pay in 4 interest-free payments of $6.89 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC Class II senolytics inhibit survival pathways elicited by senescent Download Scientific Diagram FOXO4 DRI For Sale (10mg) Core Peptides The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes

Store: oogcentrumvisie.be · Domain: oogcentrumvisie.be

Description

This dual-domain relevance situates it at the interface of neurophysiology and hormonal rhythm research